|
|
Daniel J. Drucker
J Clin Invest. 2007;
117(1):24
doi:10.1172/JCI30076
Abstract |
Full text
| PDF
T
he gastrointestinal tract has a crucial role in the control of energy
homeostasis through its role in the digestion, absorption, and assimilation of
ingested nutrients. Furthermore, signals from the gastrointestinal tract are
important regulators of gut motility and satiety, both of which have
implications for the long-term control of body weight. Among the specialized
cell types in the gastrointestinal mucosa, enteroendocrine cells have important
roles in regulating energy intake and glucose homeostasis through their actions
on peripheral target organs, including the endocrine pancreas. This article
reviews the biological actions of gut hormones regulating glucose homeostasis,
with an emphasis on mechanisms of action and the emerging therapeutic roles of
gut hormones for the treatment of type 2 diabetes mellitus.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(91)
| Title and authors |
Publication |
Year |
Effects of somatostatin analogs on glucose homeostasis in rats
H. A. Schmid, J. Brueggen
|
Journal of Endocrinology
|
2012 |
Oit1/Fam3D, a gut-secreted protein displaying nutritional status-dependent regulation
Nicole J.W. de Wit, Noortje IJssennagger, Els Oosterink, Shohreh Keshtkar, Guido J.E.J. Hooiveld, Ronald P. Mensink, Sebastiaan Hammer, Johannes W.A. Smit, Michael Müller, Roelof van der Meer
|
The Journal of Nutritional Biochemistry
|
2012 |
Comparison of Metabolic Effects of Surgical-Induced Massive Weight Loss in Patients with Long-Term Remission Versus Non-remission of Type 2 Diabetes
Fernanda Filgueira Hirsch, Jose Carlos Pareja, Sylka Rodovalho Geloneze, Elinton Chaim, Everton Cazzo, Bruno Geloneze
|
OBES SURG
|
2012 |
Saxagliptin : A Review of its Use as Combination Therapy in the Management of Type 2 Diabetes Mellitus in the EU
Lily P.H. Yang
|
Drugs
|
2012 |
Safety of Antidiabetic Therapies on Bone
Beata Lecka-Czernik
|
Clinic Rev Bone Miner Metab
|
2012 |
Effects of ileal interposition on glucose metabolism in obese rats with diabetes
Fumie Ikezawa, Chikashi Shibata, Daisuke Kikuchi, Hirofumi Imoto, Koh Miura, Takeshi Naitoh, Hitoshi Ogawa, Iwao Sasaki, Takashi Tsuchiya
|
Surgery
|
2012 |
Arx is required for normal enteroendocrine cell development in mice and humans
Aiping Du, Kyle W. McCracken, Erik Walp, Natalie A. Terry, Thomas J. Klein, Annie Han, James M. Wells, Catherine Lee May
|
Developmental Biology
|
2012 |
Effect of saxagliptin as add-on therapy in patients with poorly controlled type 2 diabetes on insulin alone or insulin combined with metformin
Anthony H. Barnett, Bernard Charbonnel, Mark Donovan, Douglas Fleming
|
Curr Med Res Opin
|
2012 |
Metabolic Syndrome
C. H. S. McIntosh, S.-J. Kim, R. A. Pederson, U. Heiser, H.-U. Demuth
|
Metabolic Syndrome
|
2011 |
The emerging role of the intestine in metabolic diseases
William D. Bradley, Catherine Zwingelstein, Cristina M. Rondinone
|
Archives of Physiology and Biochemistry
|
2011 |
|